지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2019.1
- 수록면
- 112 - 118 (7page)
이용수
초록· 키워드
오류제보하기
Purpose The purpose of this study was to develop Korean versions of the National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy (NCCN-FACT) Ovarian Symptom Index-18 (NFOSI-18) and FACT/Gynecologic Oncology Group (FACT-GOG) Neurotoxicity 4-item (NTX-4), evaluating their reliability and reproducibility. Materials and Methods In converting NFOSI-18 and NTX-4, the following steps were performed: forward translation, backward translation, expert review, pretest of preliminary format, and finalization of Korean versions (K-NFOSI-18 and K-NTX-4). Patients were enrolled from six institutions where each had completed chemotherapy for ovarian, tubal, or peritoneal cancer at least 1 month earlier. In addition to demographics obtained by questionnaire, all subjects were assessed via K-NFOSI-18, K-NTX-4, and a Korean version of the EuroQoL-5 Dimension. Internal structural validity and reliability were evaluated using item internal consistency, item discriminant validity, and Cronbach's . To evaluate test-retest reliability, K-NFOSI-18 and K-NTX-4 were readministered after 7-21 days, and intraclass correlation coefficients (ICCs) were calculated. Results Of the 250 women enrolled during the 3-month recruitment period, 13 withdrew or did not respond, leaving 237 (94.8%) for the analyses. Mean patient age was 54.3±10.8 years. Re-testing was performed in 190 patients (80.2%). The total K-NFOSI-18 and K-NTX-4 scores were 49 (range, 20 to 72) and 9 (range, 0 to 16), respectively, with high reliability (Cronbach's =0.84 and 0.89, respectively) and reproducibility (ICC=0.77 and 0.84, respectively) achieved in retesting. Conclusion Both NFOSI-18 and NTX-4 were successfully developed in Korean with minimal modification. Each Korean version showed high internal consistency and reproducibility.
목차
등록된 정보가 없습니다.
참고문헌 (19)
참고문헌 신청
Siegel RL / 2016 / Cancer statistics, 2016 / CA Cancer J Clin 66:7~30
임명철 / 2013 / Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010 / Journal of Gynecologic Oncology 24(4):298~302
Cannistra SA / 2004 / Cancer of the ovary / N Engl J Med 351:2519~2529
Ezendam NP / 2014 / Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors : results from the population-based PROFILES registry / Gynecol Oncol 135:510~517
Oronsky B / 2017 / A brief review of the management of platinum-resistantplatinum-refractory ovarian cancer / Med Oncol 34:103
임명철 / 2013 / Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010 / Journal of Gynecologic Oncology 24(4):298~302
Cannistra SA / 2004 / Cancer of the ovary / N Engl J Med 351:2519~2529
Ezendam NP / 2014 / Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors : results from the population-based PROFILES registry / Gynecol Oncol 135:510~517
Oronsky B / 2017 / A brief review of the management of platinum-resistantplatinum-refractory ovarian cancer / Med Oncol 34:103
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
Journal of Gynecologic Oncology
2021 .01
-
난소암 치료에 대한 한의 임상 가이드라인
대한암한의학회지
2016 .01
-
Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG)
Obstetrics & Gynecology Science
2018 .01
-
Novel Directions in Adjuvant Chemotherapy for Early Stage Epithelial Ovarian Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Evaluation of Effects of Metformin in Primary Ovarian Cancer Cells
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Do we need a better marker for successful ovarian cancer surgery?
Journal of Gynecologic Oncology
2017 .01
-
난소암의 수술적 치료
대한의사협회지
2016 .01
-
장액성 난소암 환자의 유전성 난소암에 대한 지식 및 불안정도
Women's Health Nursing
2019 .01
-
난소암 치료 이행성 연구의 최신 동향
대한의사협회지
2016 .01
-
Current status and future directions of ovarian cancer prognostic models
Journal of Gynecologic Oncology
2021 .01
-
난소암 여성의 투병과정 : 죽음의 굴레에 묶인 채 존재가치 찾아가기
성인간호학회지
2018 .12
-
Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer
Journal of Gynecologic Oncology
2016 .01
-
Awareness of Ovarian Cancer Risk Factors among Women in Malaysia: A Preliminary Study
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Ovarian Cancer in Children and Adolescents: Treatment and Reproductive Outcomes
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer
Journal of Gynecologic Oncology
2018 .01
-
난소암 환자의 항암화학요법 치료 경험
Asian Oncology Nursing
2017 .09
-
BRCA1/2 mutations, including large genomic rearrangements, among unselected ovarian cancer patients in Korea
Journal of Gynecologic Oncology
2018 .01
-
Public perception of risk-reducing salpingectomy for preventing ovarian cancer
Obstetrics & Gynecology Science
2015 .01
-
Clinical and histopathologic analysis of gynecological cancer: a single institute experience over 7 years
Journal of Yeungnam Medical Science
2020 .01
-
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial
Journal of Gynecologic Oncology
2024 .09
이 논문의 저자 정보
최근 본 자료
댓글(0)
0